About Innovir Biosciences Private Limited
Data last updated:
Innovir Biosciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 19 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2017PTC121328.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Santhoshalaxmi Mahamkali and Noothy Venkatesham.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.68 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.36 Lakh (net margin -12.6%) and EBITDA of -₹57,378 (EBITDA margin -2.2%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 18% over five years.
The company is associated with 1 brand: Innovir Biosciences.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website innovirbio.com.
Company details
Contact details
Innovir Biosciences Private Limited's registered office is in Hyderabad, Telangana. Its website is innovirbio.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressShed No 31 32, Sy No 125 Part Road No 10 Ida Mallapur Uppal (M), Hyderabad, Telangana, India – 500076
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Innovir Biosciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Innovir Biosciences operates one associated brand: Innovir Biosciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers custom synthesis, analysis, and standards for pharmaceutical and agrochemical sectors. | innovirbio.com |
Business activity
The main business activity of Innovir Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innovir Biosciences Private Limited, buy the company report.
Financials of Innovir Biosciences Private Limited
FY 2025 filings availableInnovir Biosciences Private Limited reported revenue of ₹26.68 Lakh (up 403% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 403% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹57,378 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.36 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.2% | ||||
| Net Profit Margin | -12.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innovir Biosciences Private Limited, buy the company report.
Board of directors of Innovir Biosciences Private Limited
Innovir Biosciences has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santhoshalaxmi Mahamkali Also directs: Sunpro Healthcare Private Limited | Director | 23 Feb 2024 | 2 Years 8 Months | Current |
| Noothy Venkatesham Also directs: Proxima Lifesciences Private Limited | Director | 26 Aug 2021 | 5 Years 2 Months | Current |
| Govardhanreddy Kundur | Director | 26 Aug 2021 | 5 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Innovir Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innovir Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Innovir Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Innovir Biosciences Private Limited has 7 board changes on record since 2021: 3 appointments and 4 cessations. The latest: Pranitha Kodoor ceased to be Director on 15 Apr 2025.
Frequently asked questions
Innovir Biosciences is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 19 December 2017 (9+ years old) and is registered under CIN U24100TG2017PTC121328.
Innovir Biosciences has 3 current directors:
- Santhoshalaxmi Mahamkali - Director
- Noothy Venkatesham - Director
- Govardhanreddy Kundur - Director
The latest financial statements of Innovir Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Innovir Biosciences is U24100TG2017PTC121328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innovir Biosciences was incorporated on 19 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Hyderabad.
Pranitha Kodoor ceased to be Director on 15 Apr 2025. Santhoshalaxmi Mahamkali was appointed as Director on 23 Feb 2024. Lavanya Bodakuntla ceased to be Director on 05 Sep 2021. Innovir Biosciences has 7 board changes on record in total.
Innovir Biosciences can be reached through the website innovirbio.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Innovir Biosciences is at Shed No 31 32, Sy No 125 Part Road No 10 Ida Mallapur Uppal M, Hyderabad, Telangana, India – 500076.
Innovir Biosciences operates in the chemicals industry, in the manufacturing segment.
The compliance status of Innovir Biosciences is compliant as of 13 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
